The Immunologic Response to Anti-Hepatitis B Vaccination Among Medical Students of Guilan University of Medical Sciences, Guilan, Iran

Authors

F. Mansour Ghanaei1,*, M S Fallah2, R. Jafarshad2, F. Joukar2, M. Arami2, A. Ale-ESmaeil2, M. Hoseinzadeh2
1Associate Professor of Gastroenterolology & Hepatology, Gastrointestinal and Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences, [email protected], Gilan, IR.Iran
2PhD in Genetics, Gastrointestinal and Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences, Gilan, IR.Iran
*Corresponding Author: Associate Professor of Gastroenterolology & Hepatology, Gastrointestinal and Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences, [email protected], Gilan, IR.Iran. Tel: +98 131 5535116. Fax: +98 131 5534951. Email: [email protected]

Hepatitis Monthly:Vol. 6, issue 2; 63-66
Published online:Dec 31, 2006
Article type:Research Article
Received:May 01, 2006
Accepted:May 15, 2006
How to Cite:Ghanaei F, Fallah M, Jafarshad R, Joukar F, Arami M, et al. The Immunologic Response to Anti-Hepatitis B Vaccination Among Medical Students of Guilan University of Medical Sciences, Guilan, Iran. Hepat Mon. 2006;6(2):. doi:

Abstract

Background and Aims: An important way to prevent hepatitis B infection is vaccination especially among high-risk populations including healthcare workers. Unfortunately, immunologic response to the vaccine is not perfect. Multiple different factors such as gender, age, body mass index (BMI), smoking and underlying diseases can influence the immunologic response. So, this study was conducted to evaluate the post-vaccination immunologic response of medical students of Guilan University of Medical Sciences (GUMS).
Methods: In this cross-sectional study, GUMS medical students who had received complete vaccine series at zero, one, and six months were enrolled. Their demographic data and the factors which could probably alternate the immunologic response were collected by interview. The anti-HBs Ab titer was evaluated by Enzyme-Linked-Immunoassay (ELISA). Appropriate immunologic response was supposed to be HBsAb >=10 mIU/ml. The collected data were analyzed using SPSS 10.00.P value <0.05 was considered significant.
Results: We evaluated 233 students with mean age of 24.9¡4.5 years. 74.7% were female. 4.9% did not respond properly to vaccination. Females' immunologic responses were significantly higher than males' (P=0.001). Responsiveness was significantly lower in smokers than non-smokers (P=0.02). Mean age in inappropriate and appropriate responder groups were 28.67¡5.4 and 24.77|¡|4.4 years, respectively (P=0.004).
Conclusions: 95.1% of students had a protective level of anti-HBsAb (>10 mIU/ml). Since health-care staffs including medical students are a high risk group to be contaminated with HBV, it is preferable to be evaluated for anti-HBs titer 1-3 months after full three-dose vaccination especially when these factors are present; in this way the false sense of
being immunized among them may be decreased.

Full Text

Full text is available in PDF

Copyright

© 2006, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

21
Mar
2015

Post-vaccination Immunity Against Hepatitis B Virus and Predictors for Non-responders Among Medical Staff

Roohangiz Nashibi,
Seyed Mohammad Alavi,
Farid Yousefi,
Shokrolah Salmanzadeh,
Sassan Moogahi,
Fatemeh Ahmadi
,et al.

Nashibi R, Alavi SM, Yousefi F, Salmanzadeh S, Moogahi S, et al. Post-vaccination Immunity Against Hepatitis B Virus and Predictors for Non-responders Among Medical Staff. Jundishapur J Microbiol. 2015;8(3):e19579. doi: https://doi.org/10.5812/jjm.19579

12
Jun
2018

Anti-HBs Antibody Levels and Anti-HBc Detection Among HBV-Vaccinated Freshmen Enrolled in the Department of Laboratory Sciences, Shiraz University of Medical Sciences, Iran

Sepide Namdari,
Rita Arabsolghar,
Sedigheh Sharifzadeh,
Ali Farhadi,
Shamim Toopchi,
Noorossadat Seyyedi
,et al.

Namdari S, Arabsolghar R, Sharifzadeh S, Farhadi A, Toopchi S, et al. Anti-HBs Antibody Levels and Anti-HBc Detection Among HBV-Vaccinated Freshmen Enrolled in the Department of Laboratory Sciences, Shiraz University of Medical Sciences, Iran. Shiraz E-Med J. 2018;19(7):e64831. doi: https://doi.org/10.5812/semj.64831

29
Nov
2024
Hepatitis B Virus Immunity Status and Booster Dose Efficacy in Health Sciences Students: An Interventional Study

Hepatitis B Virus Immunity Status and Booster Dose Efficacy in Health Sciences Students: An Interventional Study

Seyyed Javad Hosseini Shokouh,
Iman Naseh,
Mohamad Barati,
Mohammad Gholami,
Alireza Farkhonderay

Hosseini Shokouh SJ, Naseh I, Barati M, Gholami M, Farkhonderay A. Hepatitis B Virus Immunity Status and Booster Dose Efficacy in Health Sciences Students: An Interventional Study. Ann Mil Health Sci Res. 2024;22(4):e153329. doi: https://doi.org/10.5812/amh-153329

6
Dec
2014

Evaluation of Hepatitis B Surface Antibody and Specific Gamma Interferon Response in Health Care Workers After Vaccination

Mohammad Hosein Sarmast Shooshtari,
Manoochehr Makvandi,
Mojtaba Rasti,
Niloofar Neisi,
Nasrin Rastegarvand,
Amir Pouremamali
,et al.

Sarmast Shooshtari MH, Makvandi M, Rasti M, Neisi N, Rastegarvand N, et al. Evaluation of Hepatitis B Surface Antibody and Specific Gamma Interferon Response in Health Care Workers After Vaccination. Jundishapur J Microbiol. 2015;8(1):e59742. doi: https://doi.org/10.5812/jjm.13801

30
Apr
2006

Immunogenicity of recombinant hepatitis B vaccine in health care worker of Boo-Ali hospital in Tehran, Iran, 2002-2004

Nikdokht Taghavi,
Orang Eilami,
Mahmoud Nabavi,
Eznollah Azargashb,
Davod Yadegarynia,
Afshin Mohammad Alizadeh

Taghavi N, Eilami O, Nabavi M, Azargashb E, Yadegarynia D, et al. Immunogenicity of recombinant hepatitis B vaccine in health care worker of Boo-Ali hospital in Tehran, Iran, 2002-2004. Arch Clin Infect Dis. 2006;1(2):. doi:

More by these authors

F. GhanaeiPubMedScholar
R. JafarshadPubMedScholar
F. JoukarPubMedScholar
A. Ale-ESmaeilPubMedScholar
M. HoseinzadehPubMedScholar
Share
Cited by
Metrics